{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T04:28:56Z","timestamp":1790224136273,"version":"4.1.0"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2026,2,9]],"date-time":"2026-02-09T00:00:00Z","timestamp":1770595200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,9]],"date-time":"2026-02-09T00:00:00Z","timestamp":1770595200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100000053","name":"National Eye Institute","doi-asserted-by":"crossref","award":["R01EY031041"],"award-info":[{"award-number":["R01EY031041"]}],"id":[{"id":"10.13039\/100000053","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000053","name":"National Eye Institute","doi-asserted-by":"crossref","award":["P30EY001765"],"award-info":[{"award-number":["P30EY001765"]}],"id":[{"id":"10.13039\/100000053","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000053","name":"National Eye Institute","doi-asserted-by":"crossref","award":["T32EY007143"],"award-info":[{"award-number":["T32EY007143"]}],"id":[{"id":"10.13039\/100000053","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Drug Deliv. and Transl. Res."],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1007\/s13346-026-02070-4","type":"journal-article","created":{"date-parts":[[2026,2,9]],"date-time":"2026-02-09T14:41:44Z","timestamp":1770648104000},"page":"1052-1063","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["A gel-forming antioxidant eye drop for photoreceptor protection in retinitis pigmentosa"],"prefix":"10.1007","volume":"16","author":[{"given":"Matthew B.","family":"Appell","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yogita","family":"Kanan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiersten","family":"Malmberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tejaswini","family":"Appidi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahmood","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter A.","family":"Campochiaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura M.","family":"Ensign","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,9]]},"reference":[{"key":"2070_CR1","doi-asserted-by":"publisher","first-page":"1993","DOI":"10.2147\/OPTH.S365486","volume":"16","author":"N Cross","year":"2022","unstructured":"Cross N, van Steen C, Zegaoui Y, Satherley A, Angelillo L. Retinitis pigmentosa: burden of disease and current unmet needs. Clin Ophthalmol. 2022;16:1993\u20132010. https:\/\/doi.org\/10.2147\/OPTH.S365486.","journal-title":"Clin Ophthalmol"},{"issue":"9549","key":"2070_CR2","doi-asserted-by":"publisher","first-page":"1795","DOI":"10.1016\/S0140-6736(06)69740-7","volume":"368","author":"DT Hartong","year":"2006","unstructured":"Hartong DT, Berson EL, Dryja TP. Retinitis pigmentosa. Lancet. 2006;368(9549):1795\u2013809. https:\/\/doi.org\/10.1016\/S0140-6736(06)69740-7.","journal-title":"Lancet"},{"issue":"3","key":"2070_CR3","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1007\/s12325-021-02036-7","volume":"39","author":"JMF Sallum","year":"2022","unstructured":"Sallum JMF, Kaur VP, Shaikh J, Banhazi J, Spera C, Aouadj C, Viriato D, Fischer MD. Epidemiology of mutations in the 65-kDa retinal pigment epithelium (RPE65) gene-mediated inherited retinal dystrophies: a systematic literature review. Adv Ther. 2022;39(3):1179\u201398. https:\/\/doi.org\/10.1007\/s12325-021-02036-7.","journal-title":"Adv Ther"},{"issue":"2","key":"2070_CR4","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1111\/cge.12203","volume":"84","author":"SP Daiger","year":"2013","unstructured":"Daiger SP, Sullivan LS, Bowne SJ. Genes and mutations causing retinitis pigmentosa. Clin Genet. 2013;84(2):132\u201341. https:\/\/doi.org\/10.1111\/cge.12203.","journal-title":"Clin Genet"},{"key":"2070_CR5","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.preteyeres.2015.09.003","volume":"50","author":"YH Luo","year":"2016","unstructured":"Luo YH, da Cruz L. The Argus((R)) II retinal prosthesis system. Prog Retin Eye Res. 2016;50:89\u2013107. https:\/\/doi.org\/10.1016\/j.preteyeres.2015.09.003.","journal-title":"Prog Retin Eye Res"},{"issue":"2","key":"2070_CR6","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.preteyeres.2010.11.001","volume":"30","author":"JS Wang","year":"2011","unstructured":"Wang JS, Kefalov VJ. The cone-specific visual cycle. Prog Retin Eye Res. 2011;30(2):115\u201328. https:\/\/doi.org\/10.1016\/j.preteyeres.2010.11.001.","journal-title":"Prog Retin Eye Res"},{"key":"2070_CR7","unstructured":"Yu DY, Cringle SJ, Su EN, Yu PK. Intraretinal oxygen levels before and after photoreceptor loss in the RCS rat. Invest Ophth Vis Sci. 2000;41(12):3999\u20134006. PubMed PMID: WOS:000165066400046."},{"issue":"3","key":"2070_CR8","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1002\/jcp.20346","volume":"203","author":"J Shen","year":"2005","unstructured":"Shen J, Yang X, Dong A, Petters RM, Peng YW, Wong F, Campochiaro PA. Oxidative damage is a potential cause of cone cell death in retinitis pigmentosa. J Cell Physiol. 2005;203(3):457\u201364. https:\/\/doi.org\/10.1002\/jcp.20346.","journal-title":"J Cell Physiol"},{"key":"2070_CR9","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.freeradbiomed.2023.01.021","volume":"198","author":"Y Kanan","year":"2023","unstructured":"Kanan Y, Hackett SF, Hsueh HT, Khan M, Ensign LM, Campochiaro PA. Reduced inspired oxygen decreases retinal superoxide radicals and promotes cone function and survival in a model of retinitis pigmentosa. Free Radic Biol Med. 2023;198:118\u201322. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2023.01.021.","journal-title":"Free Radic Biol Med"},{"key":"2070_CR10","doi-asserted-by":"publisher","DOI":"10.3390\/antiox8040082","author":"DH Kwon","year":"2019","unstructured":"Kwon DH, Cha HJ, Lee H, Hong SH, Park C, Park SH, Kim GY, Kim S, Kim HS, Hwang HJ, Choi YH. Protective effect of glutathione against oxidative stress-induced cytotoxicity in RAW 264.7 macrophages through activating the nuclear factor erythroid 2-related factor-2\/heme oxygenase-1 pathway. Antioxidants. 2019. https:\/\/doi.org\/10.3390\/antiox8040082.","journal-title":"Antioxidants"},{"issue":"3","key":"2070_CR11","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1002\/jcp.20346","volume":"203","author":"JK Shen","year":"2005","unstructured":"Shen JK, Yang XR, Dong AL, Petters RM, Peng YW, Wong F, Campochiaro PA. Oxidative damage is a potential cause of cone cell death in retinitis pigmentosa. J Cell Physiol. 2005;203(3):457\u201364. https:\/\/doi.org\/10.1002\/jcp.20346.","journal-title":"J Cell Physiol"},{"issue":"7","key":"2070_CR12","doi-asserted-by":"publisher","first-page":"1843","DOI":"10.1002\/jcp.22508","volume":"226","author":"SY Lee","year":"2011","unstructured":"Lee SY, Usui S, Zafar AB, Oveson BC, Jo YJ, Lu LL, Masoudi S, Campochiaro PA. -acetylcysteine promotes long-term survival of cones in a model of retinitis pigmentosa. J Cell Physiol. 2011;226(7):1843\u20139. https:\/\/doi.org\/10.1002\/jcp.22508.","journal-title":"J Cell Physiol"},{"issue":"3","key":"2070_CR13","doi-asserted-by":"publisher","first-page":"1527","DOI":"10.1172\/Jci132990","volume":"130","author":"PA Campochiaro","year":"2020","unstructured":"Campochiaro PA, Iftikhar M, Hafiz G, Akhlaq A, Tsai G, Wehling D, Lu LL, Wall GM, Singh MS, Kong XR. Oral N-acetylcysteine improves cone function in retinitis pigmentosa patients in phase I trial. J Clin Invest. 2020;130(3):1527\u201341. https:\/\/doi.org\/10.1172\/Jci132990.","journal-title":"J Clin Invest"},{"key":"2070_CR14","unstructured":"Study Details: Oral N-acetylcysteine for Retinitis Pigmentosa ClinicalTrials.gov [July 5, 2024]. Available from: https:\/\/clinicaltrials.gov\/study\/NCT05537220."},{"issue":"2","key":"2070_CR15","doi-asserted-by":"publisher","first-page":"47","DOI":"10.5497\/wjp.v2.i2.47","volume":"2","author":"A Patel","year":"2013","unstructured":"Patel A, Cholkar K, Agrahari V, Mitra AK. Ocular drug delivery systems: an overview. World J Pharmacol. 2013;2(2):47\u201364. https:\/\/doi.org\/10.5497\/wjp.v2.i2.47.","journal-title":"World J Pharmacol"},{"issue":"3","key":"2070_CR16","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1208\/s12248-010-9183-3","volume":"12","author":"R Gaudana","year":"2010","unstructured":"Gaudana R, Ananthula HK, Parenky A, Mitra AK. Ocular drug delivery. AAPS J. 2010;12(3):348\u201360. https:\/\/doi.org\/10.1208\/s12248-010-9183-3.","journal-title":"AAPS J"},{"issue":"2","key":"2070_CR17","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/s1350-9462(01)00018-0","volume":"21","author":"J Ambati","year":"2002","unstructured":"Ambati J, Adamis AP. Transscleral drug delivery to the retina and choroid. Prog Retin Eye Res. 2002;21(2):145\u201351. https:\/\/doi.org\/10.1016\/s1350-9462(01)00018-0.","journal-title":"Prog Retin Eye Res"},{"key":"2070_CR18","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics14010134","author":"M Loscher","year":"2022","unstructured":"Loscher M, Seiz C, Hurst J, Schnichels S. Topical drug delivery to the posterior segment of the eye. Pharmaceutics. 2022. https:\/\/doi.org\/10.3390\/pharmaceutics14010134.","journal-title":"Pharmaceutics"},{"key":"2070_CR19","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics14061150","author":"Y Wang","year":"2022","unstructured":"Wang Y, Wang C. Novel eye drop delivery systems: advance on formulation design strategies targeting anterior and posterior segments of the eye. Pharmaceutics. 2022. https:\/\/doi.org\/10.3390\/pharmaceutics14061150.","journal-title":"Pharmaceutics"},{"issue":"11","key":"2070_CR20","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1038\/s41551-020-00606-8","volume":"4","author":"YC Kim","year":"2020","unstructured":"Kim YC, Shin MD, Hackett SF, Hsueh HT, Lima ESR, Date A, Han H, Kim BJ, Xiao A, Kim Y, Ogunnaike L, Anders NM, Hemingway A, He P, Jun AS, McDonnell PJ, Eberhart C, Pitha I, Zack DJ, Campochiaro PA, Hanes J, Ensign LM. Gelling hypotonic polymer solution for extended topical drug delivery to the eye. Nat Biomed Eng. 2020;4(11):1053\u201362. https:\/\/doi.org\/10.1038\/s41551-020-00606-8.","journal-title":"Nat Biomed Eng"},{"issue":"4","key":"2070_CR21","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1007\/s13346-021-00987-6","volume":"12","author":"YC Kim","year":"2022","unstructured":"Kim YC, Hsueh HT, Shin MD, Berlinicke CA, Han H, Anders NM, Hemingway A, Leo KT, Chou RT, Kwon H, Appell MB, Rai U, Kolodziejski P, Eberhart C, Pitha I, Zack DJ, Hanes J, Ensign LM. A hypotonic gel-forming eye drop provides enhanced intraocular delivery of a kinase inhibitor with melanin-binding properties for sustained protection of retinal ganglion cells. Drug Deliv Transl Res. 2022;12(4):826\u201337. https:\/\/doi.org\/10.1007\/s13346-021-00987-6.","journal-title":"Drug Deliv Transl Res"},{"key":"2070_CR22","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22020600","author":"GM Tosi","year":"2021","unstructured":"Tosi GM, Giustarini D, Franci L, Minetti A, Imperatore F, Caldi E, Fiorenzani P, Aloisi AM, Sparatore A, Rossi R, Chiariello M, Orlandini M, Galvagni F. Superior properties of N-Acetylcysteine ethyl ester over N-Acetyl cysteine to prevent retinal pigment epithelial cells oxidative damage. Int J Mol Sci. 2021. https:\/\/doi.org\/10.3390\/ijms22020600.","journal-title":"Int J Mol Sci"},{"issue":"11","key":"2070_CR23","doi-asserted-by":"publisher","first-page":"1522","DOI":"10.1016\/j.bcp.2012.09.010","volume":"84","author":"D Giustarini","year":"2012","unstructured":"Giustarini D, Milzani A, Dalle-Donne I, Tsikas D, Rossi R. N-acetylcysteine ethyl ester (NACET): a novel lipophilic cell-permeable cysteine derivative with an unusual pharmacokinetic feature and remarkable antioxidant potential. Biochem Pharmacol. 2012;84(11):1522\u201333. https:\/\/doi.org\/10.1016\/j.bcp.2012.09.010.","journal-title":"Biochem Pharmacol"},{"issue":"2","key":"2070_CR24","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1006\/exer.1996.0020","volume":"62","author":"KC Dunn","year":"1996","unstructured":"Dunn KC, Aotaki-Keen AE, Putkey FR, Hjelmeland LM. ARPE-19, a human retinal pigment epithelial cell line with differentiated properties. Exp Eye Res. 1996;62(2):155\u201369. https:\/\/doi.org\/10.1006\/exer.1996.0020.","journal-title":"Exp Eye Res"},{"key":"2070_CR25","doi-asserted-by":"publisher","DOI":"10.3390\/molecules27248970","author":"WK Jung","year":"2022","unstructured":"Jung WK, Park SB, Yu HY, Kim YH, Kim J. Effect of Esculetin on Tert-Butyl Hydroperoxide-Induced Oxidative Injury in Retinal Pigment Epithelial Cells In Vitro. Molecules. 2022. https:\/\/doi.org\/10.3390\/molecules27248970.","journal-title":"Molecules"},{"issue":"1","key":"2070_CR26","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.arabjc.2009.12.008","volume":"3","author":"I G\u00fcl\u00e7in","year":"2010","unstructured":"G\u00fcl\u00e7in I, Huyut Z, Elmastas M, Aboul-Enein HY. Radical scavenging and antioxidant activity of tannic acid. Arab J Chem. 2010;3(1):43\u201353. https:\/\/doi.org\/10.1016\/j.arabjc.2009.12.008.","journal-title":"Arab J Chem"},{"issue":"1","key":"2070_CR27","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1080\/15569527.2017.1347942","volume":"37","author":"M Cristaldi","year":"2018","unstructured":"Cristaldi M, Olivieri M, Lupo G, Anfuso CD, Pezzino S, Rusciano D. N-hydroxymethylglycinate with EDTA is an efficient eye drop preservative with very low toxicity: an comparative study. Cutan Ocul Toxicol. 2018;37(1):71\u20136. https:\/\/doi.org\/10.1080\/15569527.2017.1347942.","journal-title":"Cutan Ocul Toxicol"},{"issue":"1","key":"2070_CR28","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-34382-7","volume":"13","author":"L Angeli","year":"2023","unstructured":"Angeli L, Morozova K, Scampicchio M. A kinetic-based stopped-flow DPPH method. Sci Rep. 2023;13(1). https:\/\/doi.org\/10.1038\/s41598-023-34382-7.","journal-title":"Sci Rep"},{"key":"2070_CR29","unstructured":"Accelerated ageing calculator for stability testing [July 5, 2024]. Available from: https:\/\/www.glass-ts.com\/resources\/accelerated-ageing-calculator-for-stability-testing\/."},{"key":"2070_CR30","unstructured":"Accelerated Aging Time Calculator | Keystone Compliance | ISO 17025 Accredited Lab [July 5, 2024]. Available from: https:\/\/keystonecompliance.com\/aat-calculator."},{"key":"2070_CR31","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.freeradbiomed.2025.02.024","volume":"231","author":"Y Kanan","year":"2025","unstructured":"Kanan Y, Zhang J, Bernardo-Colon A, Debnath S, Khan M, Becerra SP, Campochiaro PA. Rabbit model of oxidative stress-induced retinal degeneration. Free Radic Biol Med. 2025;231:48\u201356. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2025.02.024.","journal-title":"Free Radic Biol Med"},{"issue":"4","key":"2070_CR32","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1016\/j.freeradbiomed.2005.09.032","volume":"40","author":"C Cingolani","year":"2006","unstructured":"Cingolani C, Rogers B, Lu L, Kachi S, Shen J, Campochiaro PA. Retinal degeneration from oxidative damage. Free Radic Biol Med. 2006;40(4):660\u20139. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2005.09.032.","journal-title":"Free Radic Biol Med"},{"issue":"40","key":"2070_CR33","doi-asserted-by":"publisher","first-page":"15332","DOI":"10.1074\/jbc.RA118.004459","volume":"293","author":"T Wang","year":"2018","unstructured":"Wang T, Reingruber J, Woodruff ML, Majumder A, Camarena A, Artemyev NO, Fain GL, Chen J. The PDE6 mutation in the rd10 retinal degeneration mouse model causes protein mislocalization and instability and promotes cell death through increased ion influx. J Biol Chem. 2018;293(40):15332\u201346. https:\/\/doi.org\/10.1074\/jbc.RA118.004459.","journal-title":"J Biol Chem"},{"issue":"21","key":"2070_CR34","doi-asserted-by":"publisher","first-page":"8936","DOI":"10.1523\/JNEUROSCI.18-21-08936.1998","volume":"18","author":"CJ Jeon","year":"1998","unstructured":"Jeon CJ, Strettoi E, Masland RH. The major cell populations of the mouse retina. J Neurosci. 1998;18(21):8936\u201346. https:\/\/doi.org\/10.1523\/JNEUROSCI.18-21-08936.1998.","journal-title":"J Neurosci"},{"issue":"2","key":"2070_CR35","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/0039-9140(94)80110-x","volume":"41","author":"IB Butler","year":"1994","unstructured":"Butler IB, Schoonen MA, Rickard DT. Removal of dissolved oxygen from water: a comparison of four common techniques. Talanta. 1994;41(2):211\u20135. https:\/\/doi.org\/10.1016\/0039-9140(94)80110-x.","journal-title":"Talanta"},{"issue":"6","key":"2070_CR36","doi-asserted-by":"publisher","first-page":"3088","DOI":"10.1073\/pnas.95.6.3088","volume":"95","author":"H Morimura","year":"1998","unstructured":"Morimura H, Fishman GA, Grover SA, Fulton AB, Berson EL, Dryja TP. Mutations in the RPE65 gene in patients with autosomal recessive retinitis pigmentosa or leber congenital amaurosis. Proc Natl Acad Sci U S A. 1998;95(6):3088\u201393. https:\/\/doi.org\/10.1073\/pnas.95.6.3088.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"13","key":"2070_CR37","doi-asserted-by":"publisher","first-page":"2504","DOI":"10.1038\/s41433-024-03065-6","volume":"38","author":"F Testa","year":"2024","unstructured":"Testa F, Bacci G, Falsini B, Iarossi G, Melillo P, Mucciolo DP, Murro V, Salvetti AP, Sodi A, Staurenghi G, Simonelli F. Voretigene neparvovec for inherited retinal dystrophy due to RPE65 mutations: a scoping review of eligibility and treatment challenges from clinical trials to real practice. Eye. 2024;38(13):2504\u201315. https:\/\/doi.org\/10.1038\/s41433-024-03065-6.","journal-title":"Eye"},{"key":"2070_CR38","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/j.ajo.2022.03.014","volume":"239","author":"RH Rosa","year":"2022","unstructured":"Rosa RH, Xie WK, Zhao M, Tsai SH, Roddy GW, Su MG, Potts LB, Hein TW, Kuo L. Intravitreal administration of Stanniocalcin-1 rescues photoreceptor degeneration with reduced oxidative stress and inflammation in a porcine model of retinitis pigmentosa. Am J Ophthalmol. 2022;239:230\u201343. https:\/\/doi.org\/10.1016\/j.ajo.2022.03.014.","journal-title":"Am J Ophthalmol"},{"issue":"3-4","key":"2070_CR39","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1089\/hum.2019.297","volume":"31","author":"VL Dufour","year":"2020","unstructured":"Dufour VL, Cideciyan AV, Ye GJ, Song CJ, Timmers A, Habecker PL, Pan W, Weinstein NM, Swider M, Durham AC, Ying GS, Robinson PM, Jacobson SG, Knop DR, Chulay JD, Shearman MS, Aguirre GD, Beltran WA. Toxicity and efficacy evaluation of an adeno-associated virus vector expressing codon-optimized RPGR delivered by subretinal injection in a canine model of X-linked retinitis pigmentosa. Hum Gene Ther. 2020;31(3\u20134):253\u201367. https:\/\/doi.org\/10.1089\/hum.2019.297.","journal-title":"Hum Gene Ther"},{"key":"2070_CR40","doi-asserted-by":"publisher","DOI":"10.3390\/medicina57111218","author":"K Teder","year":"2021","unstructured":"Teder K, Maddison L, Soeorg H, Meos A, Karjagin J. The pharmacokinetic profile and bioavailability of enteral N-acetylcysteine in intensive care unit. Medicina Kaunas. 2021. https:\/\/doi.org\/10.3390\/medicina57111218.","journal-title":"Medicina Kaunas"},{"key":"2070_CR41","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.ajo.2022.02.019","volume":"239","author":"SH Poor","year":"2022","unstructured":"Poor SH, Weissgerber G, Adams CM, Bhatt H, Browning DJ, Chastain J, Ciulla TA, Ferriere M, Gedif K, Glazer LC, Joondeph BC, Normand G, Sheth V, Watters C, Grosskreutz CL. A randomized, double-masked, multicenter trial of topical acrizanib (LHA510), a tyrosine kinase VEGF-receptor inhibitor, in treatment-experienced subjects with neovascular age-related macular degeneration. Am J Ophthalmol. 2022;239:180\u20139. https:\/\/doi.org\/10.1016\/j.ajo.2022.02.019.","journal-title":"Am J Ophthalmol"},{"issue":"12","key":"2070_CR42","doi-asserted-by":"publisher","first-page":"6131","DOI":"10.1167\/iovs.10-5637","volume":"51","author":"WT Wong","year":"2010","unstructured":"Wong WT, Kam W, Cunningham D, Harrington M, Hammel K, Meyerle CB, Cukras C, Chew EY, Sadda SR, Ferris FL. Treatment of geographic atrophy by the topical administration of OT-551: results of a phase II clinical trial. Invest Ophthalmol Vis Sci. 2010;51(12):6131\u20139. https:\/\/doi.org\/10.1167\/iovs.10-5637.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"2070_CR43","unstructured":"Study Details | OT-551 Antioxidant Eye Drops to Treat Geographic Atrophy in Age-Related Macular Degeneration | ClinicalTrials.gov [July 5, 2024]. Available from: https:\/\/clinicaltrials.gov\/study\/NCT00306488."},{"issue":"36","key":"2070_CR44","doi-asserted-by":"publisher","first-page":"14598","DOI":"10.1073\/pnas.1206937109","volume":"109","author":"Y Murakami","year":"2012","unstructured":"Murakami Y, Matsumoto H, Roh M, Suzuki J, Hisatomi T, Ikeda Y, Miller JW, Vavvas DG. Receptor interacting protein kinase mediates necrotic cone but not rod cell death in a mouse model of inherited degeneration. Proc Natl Acad Sci U S A. 2012;109(36):14598\u2013603. https:\/\/doi.org\/10.1073\/pnas.1206937109. Institution has filed patents on the subject of neuroprotection in retinal degenerations. Y.M., J.W.M., and D.G.V. are named inventors.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"2070_CR45","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1038\/mt.2009.47","volume":"17","author":"S Usui","year":"2009","unstructured":"Usui S, Komeima K, Lee SY, Jo YJ, Ueno S, Rogers BS, Wu Z, Shen J, Lu L, Oveson BC, Rabinovitch PS, Campochiaro PA. Increased expression of catalase and superoxide dismutase 2 reduces cone cell death in retinitis pigmentosa. Mol Ther. 2009;17(5):778\u201386. https:\/\/doi.org\/10.1038\/mt.2009.47.","journal-title":"Mol Ther"},{"issue":"1","key":"2070_CR46","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1167\/iovs.12-10473","volume":"54","author":"T Iwase","year":"2013","unstructured":"Iwase T, Oveson BC, Hashida N, Lima e Silva R, Shen J, Krauss AH, Gale DC, Adamson P, Campochiaro PA. Topical pazopanib blocks VEGF-induced vascular leakage and neovascularization in the mouse retina but is ineffective in the rabbit. Invest Ophthalmol Vis Sci. 2013;54(1):503\u201311. https:\/\/doi.org\/10.1167\/iovs.12-10473. None; J. Shen, None; A.H. Krauss, GlaxoSmithKline (E); D.C. Gale, GlaxoSmithKline (E); P. Adamson, GlaxoSmithKline (E); P.A. Campochiaro, GlaxoSmithKline (F).","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"2070_CR47","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics11070321","author":"RV Moiseev","year":"2019","unstructured":"Moiseev RV, Morrison PWJ, Steele F, Khutoryanskiy VV. Penetration enhancers in ocular drug delivery. Pharmaceutics. 2019. https:\/\/doi.org\/10.3390\/pharmaceutics11070321.","journal-title":"Pharmaceutics"},{"issue":"1-2","key":"2070_CR48","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.ijpharm.2014.06.007","volume":"472","author":"PW Morrison","year":"2014","unstructured":"Morrison PW, Khutoryanskiy VV. Enhancement in corneal permeability of riboflavin using calcium sequestering compounds. Int J Pharm. 2014;472(1\u20132):56\u201364. https:\/\/doi.org\/10.1016\/j.ijpharm.2014.06.007.","journal-title":"Int J Pharm"}],"container-title":["Drug Delivery and Translational Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13346-026-02070-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13346-026-02070-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13346-026-02070-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T14:50:56Z","timestamp":1772549456000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13346-026-02070-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,9]]},"references-count":48,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["2070"],"URL":"https:\/\/doi.org\/10.1007\/s13346-026-02070-4","relation":{},"ISSN":["2190-393X","2190-3948"],"issn-type":[{"value":"2190-393X","type":"print"},{"value":"2190-3948","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,9]]},"assertion":[{"value":"16 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All procedures, protocols, and medications were approved by the Johns Hopkins University Animal Care and Use Committee and were performed in accordance with the Association for Research in Vision and Ophthalmology statement for use of animals in ophthalmic and vision research, and the National Institutes of Health guide for the care and use of laboratory animals.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"L.M.E. is a co-inventor on patents related to topical eye drops that are licensed to Novus Vision LLC. L.M.E. is a co-founder and on the Board of Directors for Novus Vision LLC. The terms of this arrangement are being managed by the Johns Hopkins University (JHU) in accordance with its conflict-of-interest policies. P.A.C. has no conflicts directly related to manuscript, but unrelated to the manuscript serves as consultant for Cove, ExgenesisBio, Exonate, Ltd, Genentech, Neuvasq, Merck & Co Inc, and Perfuse. He has equity in Cove and JHU receives research support from Cove, Genentech, Ocular Therapeutics, Oxford Biomedica, and RegenxBio. These interests are managed in accordance with JHU policies. The other authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}